knowledge -WSS

knowledge

author：knowledge 2025-10-02 07:45:08 - browse：57

A hand in pink glove holds a blue rack that contains three tubes of blood samples — first opinion coverage from STAT — Joe Raedle/Getty Images

During my 25 years working in clinical trial operations, I’ve seen the biopharmaceutical world talk a big game about making the process easier for the sites running the trials and the patients participating in them. Everyone from trial sponsors to the Food and Drug Administration has been quick to promise simpler processes, less hassle, and better experiences for everyone involved.

But look closer, and you’ll see that these grand promises often fall apart when sponsors implement complicated plans for collecting blood, tissue and other biospecimens and impossible processes for managing those samples. Behind all the talk and regulatory guidance, there’s a reluctance to change how these essential elements of clinical trial execution are handled, putting the very ideals that sponsors are trying to uphold at risk.

The concept of site and patient centricity frequently gets reduced to addressing only superficial gestures, such as committing to promptly paying sites for their work or using tablets for conducting patient surveys. But the essence of centricity extends far beyond these surface-level measures. It lies in addressing the unseen and unmentioned complexities of clinical trials and providing real solutions that focus on truly prioritizing the needs of trial sites and participants.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Boston hospital trains restaurant workers on naloxone for overdoses

focus

WSS

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Why don't Americans have at

Artificial intelligence use in health care faces greater scrutiny in 2024

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

hotspot

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

Wildfire smoke exposes gaps in outdoor worker protections

Juul documents reveal insider tactics on political lobbying

BioMarin wins approval for gene therapy to treat hemophilia A

The White House hikes tariffs on plastic syringes made in China

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Galapagos to make CAR

State Dept. review finds Biden bears some blame for Afghanistan failures

Ebola vaccine can save some who are already sick, per new study

Medical records are filled with copy

Too many hospitalized Covid

leisure time

ACIP vaccine advisory panel sees its vacancies filled

Abbott's new heart device gets FDA advisory panel nod

Free medical tuition alone isn't enough to close gaps in primary care

Cherokee Nation medical school graduates its first class

Why Eli Lilly’s earnings didn’t quite live up to the hype

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Wikipedia

focus

hotspot

explore